Aliases & Classifications for Teratoma

MalaCards integrated aliases for Teratoma:

Name: Teratoma 12 29 52 42 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:3307
MeSH 42 D013724
NCIt 47 C3403
UMLS 69 C0039538

Summaries for Teratoma

Disease Ontology : 12 A germ cell and embryonal cancer that is an encapsulated tumor with tissue or organ components resembling normal derivatives of all three germ layers.

MalaCards based summary : Teratoma is related to malignant teratoma and ovarian cystic teratoma. An important gene associated with Teratoma is AFP (Alpha Fetoprotein), and among its related pathways/superpathways are Wnt / Hedgehog / Notch and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Carboplatin and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include ovary, testis and bone, and related phenotypes are Increased shRNA abundance (Z-score > 2) and cellular

Wikipedia : 72 A teratoma is a tumor with tissue or organ components resembling normal derivatives of more than one... more...

Related Diseases for Teratoma

Diseases in the Teratoma family:

Malignant Teratoma Adult Teratoma
Intermediate Malignant Teratoma

Diseases related to Teratoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 594)
id Related Disease Score Top Affiliating Genes
1 malignant teratoma 34.0 AFP KIT SYP
2 ovarian cystic teratoma 33.9 AFP KIT POU5F1
3 mature teratoma 32.8 AFP ENO2 NKX2-1 SYP
4 seminoma 30.6 CDX2 KRT7 SYP
5 cystadenoma 30.1 ENO2 SYP TP53
6 sebaceous adenoma 29.9 ACTC1 KIT SYP
7 adenocarcinoma in situ 29.8 CDX2 KRT7 TP53
8 glomus tumor 29.8 ENO2 KIT SYP
9 hypogonadism 29.7 AFP ENO2 SYP
10 cavernous hemangioma 29.7 ENO2 GFAP SYP
11 apocrine adenocarcinoma 29.4 AFP CDX2 KRT20 KRT7 TP53
12 ovarian large-cell neuroendocrine carcinoma 28.5 ENO2 KIT KRT7 NKX2-1 SYP
13 sacrococcygeal teratoma 12.3
14 growing teratoma syndrome 12.1
15 teratoma with malignant transformation 12.1
16 immature teratoma of ovary 11.9
17 cystic teratoma 11.9
18 gastric teratoma 11.9
19 central nervous system teratoma 11.8
20 adult teratoma 11.8
21 mature teratoma of the ovary 11.8
22 nasopharyngeal teratoma 11.8
23 pineal region teratoma 11.8
24 malignant gastric teratoma 11.8
25 mediastinum teratoma 11.8
26 mature gastric teratoma 11.8
27 extragonadal teratoma 11.7
28 fallopian tube teratoma 11.7
29 adult cystic teratoma 11.7
30 ovarian germ cell teratoma 11.7
31 intermediate malignant teratoma 11.7
32 testicular germ cell tumor 11.6
33 spinal cord intramedullary teratoma 11.6
34 adult central nervous system teratoma 11.6
35 central nervous system mature teratoma 11.6
36 central nervous system immature teratoma 11.6
37 childhood mature teratoma of the ovary 11.6
38 childhood teratoma of the ovary 11.6
39 ovarian solid teratoma 11.6
40 pineal region mature teratoma 11.6
41 pineal region immature teratoma 11.6
42 childhood immature teratoma of ovary 11.6
43 benign pericardial teratoma 11.6
44 dermoid cyst 11.6
45 adult central nervous system mature teratoma 11.6
46 adult central nervous system immature teratoma 11.6
47 ovarian fetiform teratoma 11.6
48 childhood central nervous system mature teratoma 11.6
49 childhood central nervous system immature teratoma 11.6
50 dandy-walker malformation with nasopharyngeal teratoma and diaphragmatic hernia 11.6

Graphical network of the top 20 diseases related to Teratoma:



Diseases related to Teratoma

Symptoms & Phenotypes for Teratoma

GenomeRNAi Phenotypes related to Teratoma according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-114 9.47 AFP
2 Increased shRNA abundance (Z-score > 2) GR00366-A-120 9.47 AFP
3 Increased shRNA abundance (Z-score > 2) GR00366-A-123 9.47 POU5F1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-127 9.47 POU5F1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-135 9.47 KRT7
6 Increased shRNA abundance (Z-score > 2) GR00366-A-149 9.47 POU5F1
7 Increased shRNA abundance (Z-score > 2) GR00366-A-192 9.47 AFP KRT7 POU5F1
8 Increased shRNA abundance (Z-score > 2) GR00366-A-29 9.47 AFP
9 Increased shRNA abundance (Z-score > 2) GR00366-A-32 9.47 POU5F1
10 Increased shRNA abundance (Z-score > 2) GR00366-A-63 9.47 AFP
11 Increased shRNA abundance (Z-score > 2) GR00366-A-74 9.47 KRT7 POU5F1

MGI Mouse Phenotypes related to Teratoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.18 KRT7 MNX1 NKX2-1 POU5F1 SOX2 TP53
2 behavior/neurological MP:0005386 10.17 KIT MNX1 AFP ENO2 GFAP GRN
3 homeostasis/metabolism MP:0005376 10.03 ACTC1 AFP CDX2 CGA GFAP GRN
4 endocrine/exocrine gland MP:0005379 10.02 AFP CDX2 CGA DMRT1 KIT MNX1
5 digestive/alimentary MP:0005381 9.97 CDX2 GFAP KIT MNX1 NKX2-1 POU5F1
6 nervous system MP:0003631 9.9 KIT MNX1 NKX2-1 POU5F1 SOX2 SYP
7 normal MP:0002873 9.65 ACTC1 CDX2 GFAP KIT MNX1 NKX2-1
8 reproductive system MP:0005389 9.32 AFP CDX2 CGA DMRT1 GRN KIT

Drugs & Therapeutics for Teratoma

Drugs for Teratoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 169)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Carboplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
2
Cisplatin Approved Phase 4,Phase 2,Phase 3,Phase 1 15663-27-1 84093 441203 2767
3
Etoposide Approved Phase 4,Phase 2,Phase 3,Phase 1 33419-42-0 36462
4
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1 3778-73-2 3690
5
Mechlorethamine Approved Phase 4,Phase 3,Phase 1,Phase 2 51-75-2 4033
6 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1
7 Antineoplastic Agents, Phytogenic Phase 4,Phase 2,Phase 3,Phase 1
8 Etoposide phosphate Phase 4,Phase 2,Phase 3,Phase 1
9 Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1
10 Topoisomerase Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
11
Bleomycin Approved Phase 2, Phase 3 11056-06-7 5360373
12
Lenograstim Approved Phase 2, Phase 3, Phase 1 135968-09-1
13
Paclitaxel Approved, Vet_approved Phase 2, Phase 3, Phase 1 33069-62-4 36314
14
Oxaliplatin Approved, Investigational Phase 3,Phase 2,Phase 1 61825-94-3 5310940 9887054 43805 6857599
15
Vinblastine Approved Phase 3 865-21-4 13342 241903
16
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
17
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
18
Mesna Approved Phase 3,Phase 1,Phase 2 3375-50-6 598
19
Palivizumab Approved, Investigational Phase 3 188039-54-5
20
Ribavirin Approved Phase 3 36791-04-5 37542
21
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
22
Caspofungin Approved Phase 3 179463-17-3, 162808-62-0 468682 2826718
23
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
24
Captopril Approved Phase 3 62571-86-2 44093
25
Fluconazole Approved Phase 3 86386-73-4 3365
26
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
27
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
28
Ondansetron Approved Phase 3 99614-02-5 4595
29
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
30
Diphenhydramine Approved Phase 3 58-73-1, 147-24-0 3100
31
Promethazine Approved Phase 3 60-87-7 4927
32 Albumin-Bound Paclitaxel Phase 2, Phase 3, Phase 1
33 Anti-Bacterial Agents Phase 2, Phase 3, Phase 1
34 Antibiotics, Antitubercular Phase 2, Phase 3, Phase 1
35 Antimitotic Agents Phase 2, Phase 3, Phase 1
36 Antirheumatic Agents Phase 3,Phase 2,Phase 1
37 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
38 Anti-Infective Agents Phase 3,Phase 1,Phase 2
39 Antimetabolites Phase 3,Phase 1,Phase 2
40 Antiviral Agents Phase 3,Phase 1,Phase 2
41 Hormone Antagonists Phase 3,Phase 2,Phase 1
42 Hormones Phase 3,Phase 2,Phase 1
43 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
44 Liver Extracts Phase 3,Phase 2,Phase 1
45 Antiemetics Phase 3,Phase 2,Phase 1
46 Autonomic Agents Phase 3,Phase 2,Phase 1
47 BB 1101 Phase 3,Phase 2,Phase 1
48 Dexamethasone acetate Phase 3,Phase 2,Phase 1 1177-87-3
49 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
50 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 99)

id Name Status NCT ID Phase Drugs
1 Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors Recruiting NCT01424839 Phase 4 Carboplatin, Etoposide, Ifosfamide;Cisplatin, etoposide, Ifosfamide (standard);Cisplatin, Etoposide, Ifosfamide (high dose)
2 Combination Chemotherapy in Treating Men With Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3 cisplatin;etoposide;paclitaxel
3 Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Unknown status NCT00104676 Phase 3 cisplatin;etoposide;ifosfamide;oxaliplatin;paclitaxel
4 Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy Unknown status NCT02097446 Phase 3
5 Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors Unknown status NCT00274950 Phase 3 carboplatin;cisplatin;etoposide;ifosfamide;vinblastine sulfate
6 Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors Completed NCT00002596 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide
7 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
8 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
9 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
10 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
11 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
12 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer Completed NCT00003941 Phase 3 cisplatin;etoposide;ifosfamide
13 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Completed NCT00716976 Phase 3 sodium thiosulfate
14 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
15 Single-port LC Might be Preferable for Managing Ovarian Dermoid Cyst. Completed NCT02009228 Phase 3
16 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3 Bleomycin;Carboplatin;Cisplatin;Etoposide
17 Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Recruiting NCT02375204 Phase 3 paclitaxel;ifosfamide;cisplatin;pegylated G-CSF;G-CSF;carboplatin;etoposide phosphate
18 Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Active, not recruiting NCT00053352 Phase 3 cisplatin;etoposide
19 Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Active, not recruiting NCT00085202 Phase 3 cisplatin;cyclophosphamide;vincristine
20 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Terminated NCT00072215 Phase 3 cisplatin;ifosfamide;paclitaxel;vinblastine
21 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Unknown status NCT01172912 Phase 2 carboplatin;cisplatin;dexamethasone;etoposide;ifosfamide
22 Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors Unknown status NCT00551122 Phase 1, Phase 2 cisplatin;gemcitabine hydrochloride;ifosfamide;paclitaxel
23 Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors Completed NCT00453232 Phase 2 cisplatin;etoposide
24 Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors Completed NCT00301782 Phase 2 carboplatin;cisplatin;etoposide phosphate;vincristine sulfate
25 Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Completed NCT00453310 Phase 2 sunitinib malate
26 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Completed NCT00470366 Phase 2 cisplatin;ifosfamide;paclitaxel
27 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Completed NCT00002931 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel
28 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin Completed NCT00423852 Phase 1, Phase 2 carboplatin;ifosfamide;paclitaxel
29 Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment Completed NCT00091182 Phase 2 oxaliplatin
30 Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors Completed NCT00002489 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;leucovorin calcium;methotrexate;vincristine sulfate
31 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
32 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
33 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
34 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
35 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
36 Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors Completed NCT00070096 Phase 2 ixabepilone
37 Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer Completed NCT00004077 Phase 2 cisplatin;ifosfamide;paclitaxel
38 Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors Completed NCT00047320 Phase 2 carboplatin;etoposide;ifosfamide;thiotepa
39 Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors Completed NCT00002472 Phase 2 cisplatin;etoposide
40 Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors Completed NCT00003811 Phase 2 amifostine trihydrate;cisplatin;etoposide
41 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors Completed NCT00024258 Phase 2 arsenic trioxide
42 High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors Completed NCT00003173 Phase 2 thiotepa
43 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors Completed NCT00005955 Phase 2 temozolomide
44 Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Completed NCT00047177 Phase 2 Oxaliplatin
45 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Recruiting NCT00432094 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel;thiotepa;Mesna
46 Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy Recruiting NCT02317393 Phase 2
47 PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER Recruiting NCT01037790 Phase 2 PD-0332991
48 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
49 Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors Recruiting NCT02114229 Phase 2 alisertib;methotrexate;cisplatin;carboplatin;cyclophosphamide;etoposide;topotecan;vincristine
50 A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression Active, not recruiting NCT02300987 Phase 2 LEE011;LEE011 Placebo

Search NIH Clinical Center for Teratoma

Cochrane evidence based reviews: teratoma

Genetic Tests for Teratoma

Genetic tests related to Teratoma:

id Genetic test Affiliating Genes
1 Teratoma 29

Anatomical Context for Teratoma

MalaCards organs/tissues related to Teratoma:

39
Ovary, Testis, Bone, Brain, Thyroid, Eye, Bone Marrow

Publications for Teratoma

Articles related to Teratoma:

(show top 50) (show all 2479)
id Title Authors Year
1
A Rare Case of an Autoamputated Ovary with Mature Cystic Teratoma. ( 28523263 )
2017
2
Malignant tumors associated with ovarian mature teratoma: A single institution experience. ( 28214217 )
2017
3
Anti-N-methyl-D-aspartate-receptor encephalitis due ovarian teratoma. ( 28867338 )
2017
4
Sebaceous adenoma arising in mature cystic teratoma of the ovary. Case report. ( 28248120 )
2017
5
Gastric teratoma presented as gastric outlet obstruction and melena; report of rare case. ( 28331270 )
2017
6
Massive Hemoptysis: A Rare Presentation of Anterior Mediastinal Teratoma in an Adolescent. ( 28900334 )
2017
7
Endoscopic Resection of Skull Base Teratoma in Klippel-Feil Syndrome through Use of Combined Ultrasonic and Bipolar Diathermy Platforms. ( 28133560 )
2017
8
Carcinoid Arising From the Teratomatous Bronchial Mucosa in a Mature Cystic Teratoma of the Ovary: A Case Report. ( 28777098 )
2017
9
Compact MRI for the detection of teratoma development following intrathecal human embryonic stem cell injection in NOD-SCID mice. ( 28069364 )
2017
10
De Novo Tumors of Teratoma: Ganglioneuroma Arising From a Mature Cystic Teratoma of the Ovary. ( 28700440 )
2017
11
Giant pulmonary teratoma with huge splenic lymphangiomatosis: a very rare case. ( 28928924 )
2017
12
Tumor markers and mature cystic teratoma of the ovary. ( 28882729 )
2017
13
Lower abdominal gossypiboma mimics ovarian teratoma: a case report and review of the literature. ( 28061867 )
2017
14
Mixed pineal mature teratoma and germinoma in two brothers of the fraternal triplets. ( 28236067 )
2017
15
Growing Teratoma Syndrome Following Treatment for Immature Teratoma of Ovary-A Case Report and Review of Literature. ( 28706371 )
2017
16
Intracranial monodermal teratoma presenting with growing teratoma syndrome. ( 28560020 )
2017
17
Mature Cystic Teratoma With an Element of Hepatocellular Carcinoma in Anterior Mediastinum: Magnetic Resonance-Pathologic Correlation. ( 28914742 )
2017
18
Mature Cystic Teratoma: AIRP Best Cases in Radiologic-Pathologic Correlation. ( 28898187 )
2017
19
Immature Ovarian Teratoma: When to Give Adjuvant Therapy? ( 28859031 )
2017
20
An ovarian mature cystic teratoma evolving in squamous cell carcinoma: A case report and review of the literature. ( 28050596 )
2017
21
Metastatic Mucinous Adenocarcinoma and Carcinoid Tumor Arising From a Mature Cystic Teratoma of a Horseshoe Kidney. ( 28083486 )
2017
22
Intracranial Teratoma: Imaging, Intraoperative, and Pathologic Features: AIRP Best Cases in Radiologic-Pathologic Correlation. ( 28898192 )
2017
23
Split liver transplantation for retroperitoneal immature teratoma masquerading as hepatoblastoma. ( 28714114 )
2017
24
Mature Ovarian Teratoma After Treatment for Unilateral Retinoblastoma With Nonmutated RB1. ( 28719514 )
2017
25
Simultaneous Presentation of Wilms Tumor and Immature Ovarian Teratoma in Beckwith-Wiedemann Syndrome. ( 28692553 )
2017
26
Anti-n-Methyl-d-Aspartate-Receptor (NMDAR) Encephalitis in Association with Ovarian Teratoma. ( 28884051 )
2017
27
Pediatric Ovarian Growing Teratoma Syndrome. ( 28656118 )
2017
28
Leiomyosarcoma and Squamous Cell Carcinoma Arising in Mature Cystic Teratoma of the Ovary. ( 28751996 )
2017
29
InA Vivo Generation of Engraftable Murine Hematopoietic Stem Cells by Gfi1b, c-Fos, and Gata2 Overexpression within Teratoma. ( 28943250 )
2017
30
Utilization of a submental island flap and 3D printed model for skull base reconstruction: Infantile giant cranio-cervicofacial teratoma. ( 28012516 )
2017
31
Primary retroperitoneal mature cystic teratoma (dermoid cyst) in a 51-year-old male:Case report and historical literature review. ( 28540054 )
2017
32
Successful Postnatal Management of Ruptured Giant Sacrococcygeal Teratoma. ( 28770134 )
2017
33
A Rare Case of Primary Apocrine Adenocarcinoma Arising Within a Mature Cystic Teratoma of the Ovary, Metastatic to a Supraclavicular Lymph Node. ( 28787321 )
2017
34
A Cystic Teratoma Mimicking a Hydatid Cyst. ( 28766574 )
2017
35
Growing Teratoma Syndrome. ( 28127182 )
2017
36
Laparoscopic excision of rare case of recurrent presacral teratoma. ( 28872101 )
2017
37
Multidisciplinary surgical treatment of presacral meningocele and teratoma in an adult with Currarino triad. ( 28584680 )
2017
38
Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation. ( 28370831 )
2017
39
Malignant Transformation of Mature Cystic Teratoma Diagnosed after a 10-Year Interval. ( 28607781 )
2017
40
Mature teratoma of the uterine corpus: A case report. ( 28597671 )
2017
41
A Rare Presentation of the Syndrome of Inappropriate Antidiuretic Hormone in a 12-year old Female as the Initial Presentation of an Immature Ovarian Teratoma. ( 28818586 )
2017
42
Pleural effusion as a rare manifestation of mediastinal teratoma: A case report. ( 28794967 )
2017
43
Agenesis of the dorsal pancreas associated with mucinous adenocarcinoma and cystic teratoma: a case report and literature review. ( 28174646 )
2017
44
Huge teratoma in a teenager. ( 28852533 )
2017
45
Well-formed cerebellum and brainstem-like structures in a mature ovarian teratoma: Neuropathological observations. ( 28042664 )
2017
46
Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study. ( 28657230 )
2017
47
Cushing's syndrome in infancy due to ectopic ACTH secretion by a sacro-coccygeal teratoma. ( 28328532 )
2017
48
Melanoma arising in an ovarian cystic teratoma: a systematic review of presentation, treatment, and outcomes. ( 28643027 )
2017
49
Radioactive iodine (131)I uptake in an ovarian teratoma. ( 28800880 )
2017
50
Teratoma-associated NMDAr encephalitis: management considerations. ( 28012265 )
2017

Variations for Teratoma

Expression for Teratoma

Search GEO for disease gene expression data for Teratoma.

Pathways for Teratoma

GO Terms for Teratoma

Biological processes related to Teratoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 negative regulation of transcription from RNA polymerase II promoter GO:0000122 9.8 CDX2 DMRT1 NKX2-1 POU5F1 SOX2 TP53
2 positive regulation of gene expression GO:0010628 9.65 ACTC1 KIT NKX2-1 POU5F1 TP53
3 regulation of transcription from RNA polymerase II promoter GO:0006357 9.43 CDX2 CGA CGB3 KIT MNX1 NKX2-1
4 response to wounding GO:0009611 9.4 POU5F1 SOX2
5 germ cell migration GO:0008354 9.37 DMRT1 KIT
6 endodermal cell fate specification GO:0001714 9.16 POU5F1 SOX2
7 somatic stem cell population maintenance GO:0035019 8.92 CDX2 KIT POU5F1 SOX2

Molecular functions related to Teratoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 transcription factor activity, sequence-specific DNA binding GO:0003700 9.5 CDX2 DMRT1 MNX1 NKX2-1 POU5F1 SOX2
2 sequence-specific DNA binding GO:0043565 9.1 CDX2 DMRT1 MNX1 NKX2-1 POU5F1 SOX2

Sources for Teratoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....